|
1
|
Alster TS and Tanzi EL: Hypertrophic scars
and keloids: Etiology and management. Am J Clin Dermatol.
4:235–243. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wolfram D, Tzankov A, Pülzl P and
Piza-Katzer H: Hypertrophic scars and keloids - a review of their
pathophysiology, risk factors, and therapeutic management. Dermatol
Surg. 35:171–181. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mofikoya BO, Adeyemo WL and Abdus-salam
AA: Keloid and hypertrophic scars: A review of recent developments
in pathogenesis and management. Nig Q J Hosp Med. 17:134–139.
2007.PubMed/NCBI
|
|
4
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Matouk IJ, DeGroot N, Mezan S, Ayesh S,
Abulail R, Hochberg A and Galun E: The H19 non-coding RNA is
essential for human tumor growth. PLoS One. 2:e8452007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Matouk I, Raveh E, Ohana P, Lail RA,
Gershtain E, Gilon M, De Groot N, Czerniak A and Hochberg A: The
increasing complexity of the oncofetal h19 gene locus: Functional
dissection and therapeutic intervention. Int J Mol Sci.
14:4298–4316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee JY, Yang CC, Chao SC and Wong TW:
Histopathological differential diagnosis of keloid and hypertrophic
scar. Am J Dermatopathol. 26:379–384. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Monstrey S, Middelkoop E, Vranckx JJ,
Bassetto F, Ziegler UE, Meaume S and Téot L: Updated scar
management practical guidelines: Non-invasive and invasive
measures. J Plast Reconstr Aesthet Surg. 67:1017–1025. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J
and Fang G: Upregulated long non-coding RNA H19 contributes to
proliferation of gastric cancer cells. FEBS J. 279:3159–3165. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kruger NJ: The Bradford method for protein
quantitation. Methods Mol Biol. 32:9–15. 1994.PubMed/NCBI
|
|
12
|
Calderon M, Lawrence WT and Banes AJ:
Increased proliferation in keloid fibroblasts wounded in vitro. J
Surg Res. 61:343–347. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ong CT, Khoo YT, Mukhopadhyay A, Do DV,
Lim IJ, Aalami O and Phan TT: mTOR as a potential therapeutic
target for treatment of keloids and excessive scars. Exp Dermatol.
16:394–404. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Laplante M and Sabatini DM: mTOR signaling
in growth control and disease. Cell. 149:274–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Clark JA, Leung KS, Cheng JC and Leung PC:
The hypertrophic scar and microcirculation properties. Burns.
22:447–450. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu WS, Wang FS, Yang KD, Huang CC and Kuo
YR: Dexamethasone induction of keloid regression through effective
suppression of VEGF expression and keloid fibroblast proliferation.
J Invest Dermatol. 126:1264–1271. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Crafts TD, Jensen AR, BlocherSmith EC and
Markel TA: Vascular endothelial growth factor: Therapeutic
possibilities and challenges for the treatment of ischemia.
Cytokine. 71:385–393. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Otrock ZK, Makarem JA and Shamseddine AI:
Vascular endothelial growth factor family of ligands and receptors:
Review. Blood Cells Mol Dis. 38:258–268. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Otrock ZK, Mahfouz RA, Makarem JA and
Shamseddine AI: Understanding the biology of angiogenesis: Review
of the most important molecular mechanisms. Blood Cells Mol Dis.
39:212–220. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Farhat FS, Tfayli A, Fakhruddin N, Mahfouz
R, Otrock ZK, Alameddine RS, Awada AH and Shamseddine A:
Expression, prognostic and predictive impact of VEGF and bFGF in
non-small cell lung cancer. Crit Rev Oncol Hematol. 84:149–160.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Trompezinski S, Denis A, Vinche A, Schmitt
D and Viac J: IL-4 and interferon-gamma differentially modulate
vascular endothelial growth factor release from normal human
keratinocytes and fibroblasts. Exp Dermatol. 11:224–231. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Trompezinski S, BerthierVergnes O, Denis
A, Schmitt D and Viac J: Comparative expression of vascular
endothelial growth factor family members, VEGF-B, -C and -D, by
normal human keratinocytes and fibroblasts. Exp Dermatol.
13:98–105. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
DeFelice B, Garbi C, Wilson RR,
Santoriello M and Nacca M: Effect of selenocystine on gene
expression profiles in human keloid fibroblasts. Genomics.
97:265–276. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu Z, Lou L and Luo S: Experimental study
of the expression of c-myc, c-fos and proto-oncogenes on
hypertrophic and scars. Zhonghua Zheng Xing Wai Ke Za Zhi.
18:165–167. 2002.(In Chinese). PubMed/NCBI
|
|
26
|
Bretones G, Delgado MD and León J: Myc and
cell cycle control. Biochim Biophys Acta. 1849:506–516. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
BarsyteLovejoy D, Lau SK, Boutros PC,
Khosravi F, Jurisica I, Andrulis IL, Tsao MS and Penn LZ: The c-Myc
oncogene directly induces the H19 noncoding RNA by allele-specific
binding to potentiate tumorigenesis. Cancer Res. 66:5330–5337.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luo X, Pan Q, Liu L and Chegini N: Genomic
and proteomic profiling II: Comparative assessment of gene
expression profiles in leiomyomas, keloids, and surgically-induced
scars. Reprod Biol Endocrinol. 5:352007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Berteaux N, Lottin S, Monté D, Pinte S,
Quatannens B, Coll J, Hondermarck H, Curgy JJ, Dugimont T and
Adriaenssens E: H19 mRNA-like noncoding RNA promotes breast cancer
cell proliferation through positive control by E2F1. J Biol Chem.
280:29625–29636. 2005. View Article : Google Scholar : PubMed/NCBI
|
